NS
AXSM icon

NBC Securities’s Axsome Therapeutics AXSM Stock Holding History

NBC Securities’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$397K Sell
1,623
-170
-9% -$36.9K 0.03% 615
2026
Q1 		$303K Sell
1,793
-642
-26% -$111K 0.02% 695
2025
Q4 		$445K Sell
2,435
-235
-9% -$32.8K 0.03% 540
2025
Q3 		$324K Buy
2,670
+60
+2% +$6.76K 0.02% 657
2025
Q2 		$272K Buy
2,610
+2,337
+856% +$247K 0.02% 719
2025
Q1 		$31K Buy
+273
New +$31.1K ﹤0.01% 1311
2024
Q4 		– Sell
-333
Closed -$29K – 1316
2024
Q3 		$29K Hold
333
– – ﹤0.01% 1351
2024
Q2 		$26K Hold
333
– – ﹤0.01% 1351
2024
Q1 		$26K Hold
333
– – ﹤0.01% 1360
2023
Q4 		$26K Hold
333
– – ﹤0.01% 1359
2023
Q3 		$23K Buy
+333
New +$24.9K ﹤0.01% 1389

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

NBC Securities's AXSM Position: Q2 2026 in Review

NBC Securities reduced its Axsome Therapeutics (AXSM) stake by 9.5% in Q2 2026, selling an estimated $36.9K and leaving 1,623 shares worth $397K. The position accounts for 0.03% of the portfolio, ranked #615.

NBC Securities first reported a position in AXSM in Q3 2023 and has held it in 11 quarters since. The position peaked at $445K in Q4 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • NBC Securities held 1,623 shares of Axsome Therapeutics worth $397K as of Q2 2026.
  • NBC Securities sold 170 Axsome Therapeutics shares in Q2 2026, an estimated $36.9K.
  • Axsome Therapeutics made up 0.03% of NBC Securities's portfolio in Q2 2026, its #615 holding.
  • NBC Securities first reported a position in Axsome Therapeutics in Q3 2023 and has held it in 11 quarters since.
  • NBC Securities's Axsome Therapeutics position peaked at $445K in Q4 2025.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.